JP2005516198A - ｉｎｖｉｖｏおよびｉｎｖｉｔｒｏでの方法に関する補体媒介性アッセイ - Google Patents

ｉｎｖｉｖｏおよびｉｎｖｉｔｒｏでの方法に関する補体媒介性アッセイ Download PDF

Info

Publication number
JP2005516198A
JP2005516198A JP2003563459A JP2003563459A JP2005516198A JP 2005516198 A JP2005516198 A JP 2005516198A JP 2003563459 A JP2003563459 A JP 2003563459A JP 2003563459 A JP2003563459 A JP 2003563459A JP 2005516198 A JP2005516198 A JP 2005516198A
Authority
JP
Japan
Prior art keywords
complement
prp
antibody
binding
rbc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003563459A
Other languages
English (en)
Japanese (ja)
Inventor
アール． ランバーグ，エリオット
Original Assignee
サイジーン インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by サイジーン インコーポレーテッド filed Critical サイジーン インコーポレーテッド
Publication of JP2005516198A publication Critical patent/JP2005516198A/ja
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2003563459A 2001-05-22 2002-05-22 ｉｎｖｉｖｏおよびｉｎｖｉｔｒｏでの方法に関する補体媒介性アッセイ Pending JP2005516198A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US29261601P 2001-05-22 2001-05-22
US29732101P 2001-06-11 2001-06-11
US32402901P 2001-09-21 2001-09-21
PCT/US2002/016302 WO2003063763A2 (en) 2001-05-22 2002-05-22 Complement mediated assays for in vivo and in vitro methods

Publications (1)

Publication Number Publication Date
JP2005516198A true JP2005516198A (ja) 2005-06-02

Family

ID=27670579

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003563459A Pending JP2005516198A (ja) 2001-05-22 2002-05-22 ｉｎｖｉｖｏおよびｉｎｖｉｔｒｏでの方法に関する補体媒介性アッセイ

Country Status (5)

Country Link
EP (1) EP1506314A4 (de)
JP (1) JP2005516198A (de)
AU (1) AU2002365902A1 (de)
CA (1) CA2447892A1 (de)
WO (1) WO2003063763A2 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001056456A2 (en) * 2000-02-02 2001-08-09 Cygene, Inc. Methods and compositions for detection of disease

Also Published As

Publication number Publication date
CA2447892A1 (en) 2003-08-07
WO2003063763A2 (en) 2003-08-07
WO2003063763A3 (en) 2004-12-09
EP1506314A2 (de) 2005-02-16
AU2002365902A1 (en) 2003-09-02
EP1506314A4 (de) 2005-08-24

Similar Documents

Publication Publication Date Title
JP2002527082A (ja) 疾患に関連した蛋白質の立体構造に関するアッセイ法
EP1800125A2 (de) Nachweis von proteinaggregaten mittels homologem elisa-test
US7208281B2 (en) Ligands used for detecting prions
US6709829B2 (en) Methods and compositions for detection of disease
AU2002226643B2 (en) Test for transmissible spongiform encephalopathies
JP4444644B2 (ja) 伝達性海綿状脳症の検出及び診断
AU2002226643A1 (en) Test for transmissible spongiform encephalopathies
JP2005516198A (ja) ｉｎｖｉｖｏおよびｉｎｖｉｔｒｏでの方法に関する補体媒介性アッセイ
JP2009529130A (ja) 病原性プリオン類の検出試験法
US8367391B2 (en) Method for detecting or determining abnormal prion protein associated with transmissible spongiform encephalopathy in blood-derived specimen or body fluid-derived specimen
US8663943B2 (en) Antibodies for discrimination of prions
EP1921451A2 (de) Komplement-vermittelte Assays für In-vivo- und In-vitro-Verfahren
US20050282238A1 (en) High-sensitivity chemiluminescent ELISA prion detection method
JP4049135B2 (ja) 病原性プリオン蛋白質の検出方法及びその濃縮方法、並びにその濃縮又は検出試薬キット
JP2004340924A (ja) プリオン識別抗体
EP2553465A1 (de) Verfahren zur erkennung von zu entzündungen führendem gewebeabbau
KR20070006757A (ko) Ｃｊｄ 프리온 시험
MXPA06008396A (en) Cjd prion testing
JPH03257371A (ja) 免疫学的測定方法

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060530

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20060829

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20061117

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070403